Revolution Medicines, Inc. (RVMD) CEO Mark Goldsmith on Q2 2022 Results - Earnings Call Transcript
Revolution Medicines, Inc. (RVMD) CEO Mark Goldsmith on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
3 views
You might like
Related news coverage
-
Rockwell Medical, Inc. (RMTI) CEO Mark Strobeck on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Direct Digital Holdings, Inc. (DRCT) CEO Mark Walker on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Lowell Farms Inc. (LOWLF) CEO Mark Ainsworth on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Harrow Health, Inc.'s (HROW) CEO Mark Baum on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
PaySign, Inc. (PAYS) CEO Mark Newcomer on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Energy Fuels Inc. (UUUU) CEO Mark Chalmers on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha